DAVITA INC. Letters of Credit Outstanding, Amount
DAVITA INC. (DVA) had Letters of Credit Outstanding, Amount of $0 as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Other Liabilities and Financial Instruments Subject to Mandatory Redemption
us-gaap:LettersOfCreditOutstandingAmount · last filed 2026-02-11
- 2025-12-31: Letters of Credit Outstanding, Amount $0.00.
- 2024-12-31: Letters of Credit Outstanding, Amount $0.00.
- 2023-12-31: Letters of Credit Outstanding, Amount $0.00.
- 2022-12-31: Letters of Credit Outstanding, Amount $0.00.
| Period end | Letters of Credit Outstanding, Amount |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-11 |
| 2024-12-31 | $0.00 10-K · filed 2025-02-13 |
| 2023-12-31 | $0.00 10-K · filed 2024-02-14 |
| 2022-12-31 | $0.00 10-K · filed 2023-02-22 |
| 2021-12-31 | $0.00 10-K · filed 2022-02-11 |
| 2020-09-30 | $64.63M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $57.45M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $57.70M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $59.70M 10-K · filed 2020-02-21 |
| 2019-09-30 | $59.72M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $72.76M 10-Q · filed 2019-08-02 |
| 2015-09-30 | $56.00M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $3.00M 10-Q · filed 2015-08-05 |
| 2014-09-30 | $96.00M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $83.00M 10-Q · filed 2014-08-01 |
| 2014-03-31 | $83.00M 10-Q · filed 2014-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |